- Home
- VNDA vs SGC Comparison
VNDA vs SGC Comparison
Compare VNDA & SGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- SGC
- Stock Information
- Founded
- VNDA 2002
- SGC 1920
- Country
- VNDA United States
- SGC United States
- Employees
- VNDA N/A
- SGC N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- SGC Apparel
- Sector
- VNDA Health Care
- SGC Consumer Discretionary
- Exchange
- VNDA Nasdaq
- SGC Nasdaq
- Market Cap
- VNDA 249.4M
- SGC 215.7M
- IPO Year
- VNDA 2006
- SGC N/A
- Fundamental
- Price
- VNDA $5.46
- SGC $10.23
- Analyst Decision
- VNDA Strong Buy
- SGC Strong Buy
- Analyst Count
- VNDA 2
- SGC 3
- Target Price
- VNDA $16.50
- SGC $17.33
- AVG Volume (30 Days)
- VNDA 503.6K
- SGC 41.3K
- Earning Date
- VNDA 11-05-2025
- SGC 11-05-2025
- Dividend Yield
- VNDA N/A
- SGC 5.47%
- EPS Growth
- VNDA N/A
- SGC N/A
- EPS
- VNDA N/A
- SGC 0.52
- Revenue
- VNDA $203,467,000.00
- SGC $576,240,000.00
- Revenue This Year
- VNDA $15.45
- SGC $1.76
- Revenue Next Year
- VNDA $37.82
- SGC $3.37
- P/E Ratio
- VNDA N/A
- SGC $19.60
- Revenue Growth
- VNDA 11.78
- SGC 4.03
- 52 Week Low
- VNDA $3.81
- SGC $9.11
- 52 Week High
- VNDA $5.59
- SGC $18.48
- Technical
- Relative Strength Index (RSI)
- VNDA 67.52
- SGC N/A
- Support Level
- VNDA $5.22
- SGC N/A
- Resistance Level
- VNDA $5.48
- SGC N/A
- Average True Range (ATR)
- VNDA 0.21
- SGC 0.00
- MACD
- VNDA 0.06
- SGC 0.00
- Stochastic Oscillator
- VNDA 90.31
- SGC 0.00
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About SGC Superior Group of Companies Inc.
Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.